Best Options Strategy for NVS
Looking for the best options strategy for Novartis (NVS)? There is no single answer — the right play depends on your outlook, your risk tolerance and current implied volatility. Below, our free engine shows the highest-scoring defined-risk strategy on the live NVS option chain right now, and a simple map from your view on NVS to the strategy that fits it. Model any of them in the calculator before you trade.
About NVS
Novartis (NVS) is a major company in pharmaceuticals. Options traders on NVS tend to watch drug pipeline, patent cliffs and earnings, since these can drive large moves in the share price.
NVS for options traders
Novartis trades on the NYSE as an ADR backed by a Swiss holding company, which adds a layer of currency exposure — CHF/USD movements can nudge the stock independently of its underlying business — though for most options traders the dominant drivers remain pharmaceutical catalysts: FDA and EMA approval decisions, pivotal clinical trial readouts in oncology, cardiology, and neuroscience, and quarterly earnings. Because the revenue base is broad and largely recurring, IV stays structurally low outside these events, making NVS a genuine low-volatility name in the pharma space rather than just a relatively quiet one.
That compressed baseline IV suits income-oriented strategies well. Covered calls are the most natural fit: shareholders collect premium on a slow-moving, high-quality name between catalyst windows. Short puts appeal to traders comfortable acquiring the stock at a discount if assigned. When IV rises modestly into earnings or a major pipeline announcement, short strangles or iron condors with generously wide wings can capture the subsequent compression without taking on meaningful directional exposure. Ahead of genuine binary events — a pivotal regulatory decision where the direction is uncertain — a long straddle or long strangle may be more appropriate, though NVS's typically muted realized moves mean the premium cost needs to be weighed carefully.
Today's top-scoring strategy for NVS
Our engine ranks defined-risk strategies on the live NVS chain by probability of profit and risk/reward, then surfaces the best-scoring one. It is an educational illustration, not advice.
| Action | Qty | Type | Strike | Premium |
|---|---|---|---|---|
| Buy | 1× | PUT | $135 | $0.52 |
| Sell | 1× | PUT | $155 | $4.70 |
| Sell | 1× | CALL | $155 | $6.65 |
| Buy | 1× | CALL | $175 | $0.80 |
Simulation
Forward simulation of 6,000 lognormal price paths to expiration — not a historical backtest.
Strategy analysis
Greeks vs price
Price × volatility (today)
| −30% | −15% | IV | +15% | +30% | |
|---|---|---|---|---|---|
| $195 | −$976 | −$946 | −$907 | −$865 | −$825 |
| $187 | −$913 | −$857 | −$801 | −$752 | −$713 |
| $180 | −$745 | −$676 | −$623 | −$588 | −$567 |
| $172 | −$423 | −$394 | −$385 | −$391 | −$406 |
| $164 | −$22 | −$86 | −$151 | −$213 | −$270 |
| $156 | $220 | $85 | −$30 | −$127 | −$208 |
| $148 | $82 | −$17 | −$108 | −$188 | −$257 |
| $141 | −$352 | −$349 | −$362 | −$384 | −$411 |
| $133 | −$760 | −$703 | −$661 | −$632 | −$617 |
| $125 | −$951 | −$914 | −$873 | −$835 | −$802 |
| $117 | −$994 | −$984 | −$968 | −$946 | −$922 |
Live scan from 2026-08-10 · quotes delayed ~15 minutes
Historical backtest: how a Iron Butterfly on NVS would have performed
We approximated a Iron Butterfly on NVS, entered repeatedly over the past year (91 historical entries, each held to expiration) with Black-Scholes-modelled entry premiums. Here is how that would have played out on real NVS price history — an educational backtest, not a prediction of future returns.
Approximate: entry premiums are modelled with Black-Scholes from trailing realised volatility, held to expiration and settled against the real historical close. Real fills, implied volatility and slippage differ — treat it as directional context, not exact returns.
Implied volatility
NVS is currently trading with moderate implied volatility, broadly in line with other large-cap stocks. On the options we scanned that was around 28% implied volatility, and higher implied volatility means richer premiums and wider expected moves.
Options on NVS currently price in about 28% implied volatility, versus roughly 25% the stock has actually realised over the past month. The two are roughly in line, so neither buying nor selling premium has a clear volatility edge here.
NVS's IV Rank is 78/100: implied volatility sits 78% of the way between its 30-day low (24%) and high (29%), and is above 55% of recorded days. Premium is historically rich, which favours net-credit strategies like credit spreads and iron condors.
Off that volatility, the options market is pricing a move of about ±$14.33 (±9%) in NVS by 2026-09-18 — a range of roughly $142 to $171. Strikes inside that band hold most of the premium and see most of the action.
Across strikes, downside puts on NVS trade at a higher implied volatility than upside calls — the market is paying up for crash protection. That skew favours selling put spreads or buying calls over symmetric trades.
NVS options chain highlights: open interest, volume and skew
The live NVS options chain shows a put/call open-interest ratio of 3.26 (bearish-leaning (more puts)), with at-the-money implied volatility near 28.9%. Open interest clusters at the $165 call — a common resistance "wall" — and the $130 put, a support "wall": the strikes option writers are most exposed to into expiration.
Snapshot of open interest, volume and implied volatility for the nearest scanned expiration — context, not a trading signal.
Liquidity and tradeability
NVS options are reasonably liquid, with bid-ask spreads around 9.7% near the money. Defined-risk spreads and condors are workable; use limit orders and watch the fill on wider multi-leg trades.
Earnings & IV crush
NVS's next earnings report is due around October 27, 2026. Options that expire after it price in a binary move, so their implied volatility is elevated and usually collapses right after the announcement — an "IV crush". If your expiration falls before this date, the trade sidesteps the event.
Dividend and assignment risk
NVS pays a dividend of about 3.1% a year, so short or covered calls on it carry early-assignment risk around each ex-dividend date — in-the-money calls are most exposed just before the stock goes ex-dividend.
Key figures
- Market cap
- $293.5B
- Beta (vs market)
- 0.49
- 52-week range
- $113.48–$170.46 (75% up the range)
- Short interest
- 0.3% of float · 2.7 days to cover
Other strong setups for NVS
If your view on NVS differs, these also scored well in the latest scan:
How to choose an options strategy for NVS
Start with your outlook on NVS, then match it to a defined-risk structure. Here are the most common choices and when each makes sense:
Bullish
Buy a call for leverage with capped risk, or a bull call spread to lower the cost and breakeven when you have a target price.
Long Call → Bull Call Spread →Bearish
Buy a put to profit from a decline with defined risk, or a bear put spread to cheapen the trade when you expect a measured move down.
Long Put → Bear Put Spread →Neutral
Sell an iron condor to collect premium while NVS stays between two strikes, or write a covered call against shares you already own.
Iron Condor → Covered Call →⧉ Embed this free calculator on your site →
How we pick the best strategy
For each ticker we pull the live option chain, build every supported strategy around the at-the-money strikes, and score them on probability of profit, risk/reward and capital efficiency — favouring defined-risk structures where the maximum loss is known up front. Methodology →
Open NVS in the free calculator →
Frequently asked questions
What is the best options strategy for NVS?
It depends on your outlook. Bullish traders often use a long call or bull call spread on NVS; bearish traders a long put or bear put spread; neutral traders an iron condor or covered call. Our live scan above shows the current highest-scoring defined-risk play.
Are NVS options liquid enough to trade?
Novartis (NVS) is among the most actively-traded US options, which usually means tight bid/ask spreads and plenty of strikes and expirations — though you should always check the open interest and spread on the exact contract.
How much money do I need to trade NVS options?
Buying a single NVS call or put can cost as little as the premium (often one to a few hundred dollars), while income strategies like a cash-secured put need enough capital to buy 100 shares if assigned.
Is this financial advice?
No. Everything here is educational and uses delayed, third-party data. It is not a recommendation to trade NVS or any security. Do your own research.
What does Novartis do?
Novartis (NVS) operates in the Drug Manufacturers - General industry. The "About Novartis" section above gives a fuller picture of what the company does and how it earns money.
Does Novartis pay a dividend?
Yes — Novartis currently pays a dividend yielding about 3.1%. If you hold the shares (for example to write a covered call), the ex-dividend date can trigger early assignment, so check it beforehand.
When does Novartis next report earnings?
Novartis's next earnings are expected around October 27, 2026. Implied volatility usually climbs into the report and drops sharply afterwards (IV crush) — important for any options position held over the date.
Price trend
Tickers related to NVS
Comparing NVS with similar names can help you choose the best options strategy:
Company information
- Headquarters
- Lichtstrasse 35, Basel, 4056, Switzerland
- Industry
- Drug Manufacturers - General
- Employees
- 75,267
- CEO
- Dr. Vasant Narasimhan M.D.
- Phone
- 41 61 324 11 11
- Website
- www.novartis.com
- Investor relations
- www.novartis.com/investors/index.shtml
Best Options Strategy by Ticker →
Educational use only. Quotes are delayed ~15 minutes and nothing here is financial advice. Options trading involves substantial risk of loss. Privacy · Terms.